Ironwood Pharmaceuticals | IRWD - Market Capitalization


Ironwood Pharmaceuticals reported $554.1M in Market Capitalization this April of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Acadia Pharmaceuticals USD 4.52B 919M Dec/2025
Agios Pharmaceuticals USD 1.59B 745M Dec/2025
Akebia Therapeutics USD 427M 297M Dec/2025
Almirall EUR 2.76B 472.53M Dec/2025
Alnylam Pharmaceuticals USD 52.54B 7.24B Dec/2025
Amarin USD 290M 51M Dec/2025
Ardelyx USD 1.42B 89M Dec/2025
AstraZeneca USD 288.15B 55.08B Dec/2025
Charles River Laboratories USD 10.02B 2.71B Dec/2025
Coherus Biosciences USD 172M 19M Dec/2025
Emergent BioSolutions USD 125M 51M Dec/2023
Esperion Therapeutics USD 885M 351M Dec/2025
Halozyme Therapeutics USD 7.91B 664M Dec/2025
Incyte USD 19.39B 2.83B Dec/2025
Karyopharm Therapeutics USD 652M 517M Apr/2026
Lexicon Pharmaceuticals USD 418M 73M Dec/2025
MacroGenics USD 102M 4M Dec/2025
Myriad Genetics USD 575M 98M Dec/2025
Pacira USD 1.06B 94M Dec/2025
PTC Therapeutics USD 6.1B 1.22B Dec/2025
Sarepta Therapeutics USD 2.26B 238M Dec/2025
Takeda JPY 7.64T 774.9B Dec/2025
Ultragenyx Pharmaceutical USD 2.22B 680M Dec/2025
Vanda Pharmaceuticals USD 279M 6M Dec/2024